AU2009306722A1 - Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 modulators for treating pain, epilepsy and urinary incontinence - Google Patents

Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 modulators for treating pain, epilepsy and urinary incontinence Download PDF

Info

Publication number
AU2009306722A1
AU2009306722A1 AU2009306722A AU2009306722A AU2009306722A1 AU 2009306722 A1 AU2009306722 A1 AU 2009306722A1 AU 2009306722 A AU2009306722 A AU 2009306722A AU 2009306722 A AU2009306722 A AU 2009306722A AU 2009306722 A1 AU2009306722 A1 AU 2009306722A1
Authority
AU
Australia
Prior art keywords
pyridin
dihydrothieno
phenyl
oxo
butanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009306722A
Other languages
English (en)
Inventor
Gregor Bahrenberg
Achim Kless
Sven Kuhnert
Beatrix Merla
Klaus Schiene
Wolfgang Schroder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2009306722A1 publication Critical patent/AU2009306722A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2009306722A 2008-10-24 2009-10-22 Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 modulators for treating pain, epilepsy and urinary incontinence Abandoned AU2009306722A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08018617.4 2008-10-24
EP08018617 2008-10-24
PCT/EP2009/007567 WO2010046108A1 (de) 2008-10-24 2009-10-22 Substituierte 4,5,6,7-tetrahydrothienopyridine als kcnq2/3 modulatoren zur behandlung von schmerz, epilepsie und harninkontinenz

Publications (1)

Publication Number Publication Date
AU2009306722A1 true AU2009306722A1 (en) 2010-04-29

Family

ID=40383750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009306722A Abandoned AU2009306722A1 (en) 2008-10-24 2009-10-22 Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 modulators for treating pain, epilepsy and urinary incontinence

Country Status (15)

Country Link
US (1) US20100105722A1 (pt)
EP (1) EP2350093B1 (pt)
JP (1) JP2012506395A (pt)
AU (1) AU2009306722A1 (pt)
BR (1) BRPI0919898A2 (pt)
CA (1) CA2739740A1 (pt)
CY (1) CY1113373T1 (pt)
DK (1) DK2350093T3 (pt)
ES (1) ES2392758T3 (pt)
HR (1) HRP20120822T1 (pt)
MX (1) MX2011003849A (pt)
PL (1) PL2350093T3 (pt)
PT (1) PT2350093E (pt)
SI (1) SI2350093T1 (pt)
WO (1) WO2010046108A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470852B2 (en) 2010-08-27 2013-06-25 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
MX2013002121A (es) 2010-08-27 2013-04-03 Gruenenthal Gmbh Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
JP5837934B2 (ja) 2010-08-27 2015-12-24 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Ｋｃｎｑ２／３調節因子としての置換２−オキソ−および２−チオキソ−ジヒドロキノリン−３−カルボキサミド
US8653101B2 (en) 2010-08-27 2014-02-18 Gruenenthal Gmbh Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
AR082813A1 (es) 2010-09-01 2013-01-09 Gruenenthal Gmbh 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3
NZ628871A (en) 2010-10-20 2015-07-31 Gruenenthal Chemie Substituted 6-amino-nicotinamides as kcnq2/3 modulators
US9168259B2 (en) 2010-10-20 2015-10-27 Grünenthal GmbH Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
CA2868356C (en) 2012-03-23 2020-06-23 Memorial Sloan-Kettering Cancer Center Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridines
HUE030859T2 (en) 2012-04-18 2017-06-28 Gruenenthal Gmbh Substituted 6-amino-nicotinamides bearing an OH-containing group as modulators of KCNQ2 / 3
MX2014012491A (es) 2012-04-18 2014-11-14 Grünenthal GmbH 4-aminobenzamidas sustituidas como moduladores de kcnq2/3.
AU2013351551A1 (en) 2012-11-28 2015-07-16 Grunenthal Gmbh Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
AU2013351550A1 (en) 2012-11-28 2015-07-16 Grünenthal GmbH Specific carboxamides as KCNQ2/3 modulators
WO2021212010A2 (en) * 2020-04-17 2021-10-21 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections
US11931356B1 (en) 2022-11-30 2024-03-19 The Trustees Of Indiana University Compositions and methods for treating human papilloma virus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
IL157313A0 (en) * 2001-02-20 2004-02-19 Bristol Myers Squibb Co Modulators of kcnq potassium channels and uses thereof
DK1753512T3 (da) * 2004-05-28 2008-11-17 4Sc Ag Tetrahydropyridothiophener
WO2005120642A2 (en) * 2004-06-11 2005-12-22 Altana Pharma Ag Tetrahydropyridothiophenes for treating hyperproliferative disorders
DE102006049452A1 (de) * 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
WO2009001128A1 (en) * 2007-06-26 2008-12-31 Astrazeneca Ab 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors

Also Published As

Publication number Publication date
PL2350093T3 (pl) 2013-01-31
PT2350093E (pt) 2012-11-02
DK2350093T3 (da) 2012-11-12
WO2010046108A1 (de) 2010-04-29
SI2350093T1 (sl) 2012-11-30
CY1113373T1 (el) 2016-06-22
ES2392758T3 (es) 2012-12-13
BRPI0919898A2 (pt) 2016-02-16
EP2350093B1 (de) 2012-10-03
MX2011003849A (es) 2011-05-23
JP2012506395A (ja) 2012-03-15
CA2739740A1 (en) 2010-04-29
HRP20120822T1 (hr) 2012-11-30
US20100105722A1 (en) 2010-04-29
EP2350093A1 (de) 2011-08-03

Similar Documents

Publication Publication Date Title
AU2009306722A1 (en) Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 modulators for treating pain, epilepsy and urinary incontinence
EP1218374B1 (en) Pharmaceutically active sulfonamide derivatives
JP5249772B2 (ja) キナーゼの阻害剤として有用な三環式化合物
US5585385A (en) Heterocyclic compounds, their production and use as tachykinin reactor antagonists
US8367700B2 (en) Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
CA2629466C (en) Beta-secretase modulators and methods of use
EP2435046B1 (en) Heterocyclic compounds for the treatment of stress-related conditions
KR20070113267A (ko) Ｋｓｐ 키네신 활성 억제용 화합물
NZ550775A (en) Spiro amido compounds and their use as pharmaceuticals
AU2006218449A1 (en) Phthalazine, aza- and diaza-phthalazine compounds and methods of use
CA2737472A1 (en) Azaindazole compounds as ccr1 receptor antagonists
MXPA05004670A (es) Agentes anti-infecciones.
AU2008345560A1 (en) Benzofuropyrimidinones as protein kinase inhibitors
JP2009532502A (ja) ピロロ−およびピラゾロ−ピリミジン化合物、およびそれらの使用方法
NZ534990A (en) Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
CA2607874A1 (en) Quinoline derivatives as neurokinin receptor antagonists
AU2010223512B2 (en) Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
US20100234419A1 (en) Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
AU2010223556A1 (en) Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators
US5891882A (en) Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
US9248122B2 (en) Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
AU2013351551A1 (en) Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
AU2008300945A1 (en) Substituted nicotinamide compounds and the use thereof in pharmaceutical products

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application